Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2022
Dipeptidyl peptidase IV of the Vespa velutina nigrithorax venom is recognized as a relevant allergenGabriela Pretre, Juan Andrés Asturias, María Teresa Lizaso, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 31, 2007
Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parametersMaría Teresa Lizaso, Ana Isabel Tabar, Blanca Esther García, et al.
International Archives of Allergy and Immunology|September 1, 2006
Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patientsAna Isabel Tabar, Marta Anda, Floriano Bonifazi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 28, 2011
Comparison of conventional and component-resolved diagnostics by two different methods (Advia-Centaur/Microarray-ISAC) in pollen allergyMaría Teresa Lizaso, Blanca Esther García, Ana Isabel Tabar, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2005
Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinusAna Isabel Tabar, Susana Echechipía, Blanca Esther García, et al.
European Journal of Pediatrics|August 16, 2019
Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative reviewMiguel Tortajada-Girbés, María Mesa Del Castillo, Helena Larramona, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 1, 2012
Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in childrenEva María Lasa Luaces, Ana Isabel Tabar Purroy, Blanca Esther García Figueroa, et al.
The Journal of Allergy and Clinical Immunology|March 19, 2019
Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1Ana Isabel Tabar, Luis Prieto, Pilar Alba, et al.
Pageof 1